Purple perilla extracts with α-asarone enhance cholesterol efflux from oxidized LDL-exposed macrophages

Park,Sin-Hye; Paek,Ji  Hun; Shin,Daekeun; Lee,Jae-Yong; Lim,Soon  Sung; Kang,Young-Hee

doi:10.3892/ijmm.2015.2101

Purple perilla extracts with α-asarone enhance cholesterol efflux from oxidized LDL-exposed macrophages

Authors:
- Sin-Hye Park
- Ji Hun Paek
- Daekeun Shin
- Jae-Yong Lee
- Soon Sung Lim
- Young-Hee Kang
View Affiliations

Affiliations: Department of Food Science and Nutrition, Hallym University, Chuncheon, Kangwon-do 200-702, Republic of Korea, Department of Biochemistry, School of Medicine, Hallym University, Chuncheon, Kangwon-do 200-702, Republic of Korea
Published online on: February 12, 2015 https://doi.org/10.3892/ijmm.2015.2101
Pages: 957-965
Copyright: © Park et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The cellular accumulation of cholesterol is critical in the development and progression of atherosclerosis. ATP-binding cassette (ABC) transporters play an essential role in mediating the efflux of excess cholesterol. In the current study, we investigated whether purple Perilla frutescens extracts (PPE) at a non-toxic concentration of 1-10 µg/ml stimulate the induction of the ABC transporters, ABCA1 and ABCG1, and cholesterol efflux from lipid-laden J774A.1 murine macrophages exposed to 50 ng/ml oxidized low-density lipoprotein (LDL). Purple perilla, an annual herb in the mint family and its constituents, have been reported to exhibit antioxidant and cytostatic activity, as well as to exert anti-allergic effects. Our results revealed that treatment with oxidized LDL for 24 h led to the accumulation of lipid droplets in the macrophages. PPE suppressed the oxidized LDL-induced foam cell formation by blocking the induction of scavenger receptor B1. However, PPE promoted the induction of the ABC transporters, ABCA1 and ABCG1, and subsequently accelerated cholesterol efflux from the lipid-loaded macrophages. The liver X receptor (LXR) agonist, TO-091317, and the peroxisome proliferator-activated receptor (PPAR) agonist, pioglitazone, increased ABCA1 expression and treatment with 10 µg/ml PPE further enhanced this effect. PPE did not induce LXRα and PPARγ expression per se, but enhanced their expression in the macrophages exposed to oxidized LDL. α-asarone was isolated from PPE and characterized as a major component enhancing the induction of ABCA1 and ABCG1 in macrophages exposed to oxidized LDL. α-asarone, but not β-asarone was effective in attenuating foam cell formation and enhancing cholesterol efflux, revealing an isomeric difference in their activity. The results from the present study demonstrate that PPE promotes cholesterol efflux from macrophages by activating the interaction of PPARγ-LXRα-ABC transporters.

View Figures

View References

1	Li G, Gu HM and Zhang DW: ATP-binding cassette transporters and cholesterol translocation. IUBMB Life. 65:505–512. 2013. View Article : Google Scholar : PubMed/NCBI
2	Cruz PM, Mo H, McConathy WJ, Sabnis N and Lacko AG: The role of cholesterol metabolism and cholesterol transport in carcinogenesis: A review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 4:1192013. View Article : Google Scholar : PubMed/NCBI
3	Yue P, Chen Z, Nassir F, Bernal-Mizrachi C, Finck B, Azhar S and Abumrad NA: Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice. PLoS One. 5:e99062010. View Article : Google Scholar : PubMed/NCBI
4	Wen Y and Leake DS: Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ Res. 100:1337–1343. 2007. View Article : Google Scholar : PubMed/NCBI
5	Shibata N and Glass CK: Macrophages, oxysterols and atherosclerosis. Circ J. 74:2045–2051. 2010. View Article : Google Scholar : PubMed/NCBI
6	Ye D, Lammers B, Zhao Y, Meurs I, Van Berkel TJ and Van Eck M: ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: Important targets for the treatment of atherosclerosis. Curr Drug Targets. 12:647–660. 2011. View Article : Google Scholar
7	Hafiane A and Genest J: HDL, atherosclerosis, and emerging therapies. Cholesterol. 2013:8914032013. View Article : Google Scholar : PubMed/NCBI
8	Ogata M, Tsujita M, Hossain MA, Akita N, Gonzalez FJ, Staels B, Suzuki S, Fukutomi T, Kimura G and Yokoyama S: On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis. 205:413–419. 2009. View Article : Google Scholar : PubMed/NCBI
9	Brewer HB Jr: HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease. Curr Cardiol Rep. 9:486–492. 2007. View Article : Google Scholar : PubMed/NCBI
10	Bełtowski J: Liver X receptors (LXR) as therapeutic targets in dyslipidemia. Cardiovasc Ther. 26:297–316. 2008. View Article : Google Scholar : PubMed/NCBI
11	Calkin AC and Tontonoz P: Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol. 30:1513–1518. 2010. View Article : Google Scholar : PubMed/NCBI
12	Zhu R, Ou Z, Ruan X and Gong J: Role of liver X receptors in cholesterol efflux and inflammatory signaling (Review). Mol Med Rep. 5:895–900. 2012.PubMed/NCBI
13	Neve BP, Fruchart JC and Staels B: Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol. 60:1245–1250. 2000. View Article : Google Scholar : PubMed/NCBI
14	Saita E, Kishimoto Y, Tani M, Iizuka M, Toyozaki M, Sugihara N and Kondo K: Antioxidant activities of Perilla frutescens against low-density lipoprotein oxidation in vitro and in human subjects. J Oleo Sci. 61:113–120. 2012. View Article : Google Scholar : PubMed/NCBI
15	Jun HI, Kim BT, Song GS and Kim YS: Structural characterization of phenolic antioxidants from purple perilla (Perilla frutescens var. acuta) leaves. Food Chem. 148:367–372. 2014. View Article : Google Scholar
16	Heo JC, Nam DY, Seo MS and Lee SH: Alleviation of atopic dermatitis-related symptoms by Perilla frutescens Britton. Int J Mol Med. 28:733–737. 2011.PubMed/NCBI
17	Yang SY, Hong CO, Lee GP, Kim CT and Lee KW: The hepato-protection of caffeic acid and rosmarinic acid, major compounds of Perilla frutescens, against t-BHP-induced oxidative liver damage. Food Chem Toxicol. 55:92–99. 2013. View Article : Google Scholar : PubMed/NCBI
18	Paek JH, Shin KH, Kang YH, Lee JY and Lim SS: Rapid identification of aldose reductase inhibitory compounds from Perilla frutescens. Biomed Res Int. 2013:6794632013. View Article : Google Scholar : PubMed/NCBI
19	Kim MJ and Kim HK: Perilla leaf extract ameliorates obesity and dyslipidemia induced by high-fat diet. Phytother Res. 23:1685–1690. 2009. View Article : Google Scholar : PubMed/NCBI
20	Park SH, Kim JL, Lee ES, Han SY, Gong JH, Kang MK and Kang YH: Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages. J Nutr. 141:1931–1937. 2011. View Article : Google Scholar : PubMed/NCBI
21	Park SH, Kim JL, Kang MK, Gong JH, Han SY, Shim JH, Lim SS and Kang YH: Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages. Int J Mol Med. 30:1105–1112. 2012.PubMed/NCBI
22	Wang D, Geng Y, Fang L, Shu X, Liu J, Wang X and Huang L: An efficient combination of supercritical fluid extraction and high-speed counter-current chromatography to extract and purify (E)- and (Z)-diastereomers of α-asarone and β-asarone from Acorus tatarinowii Schott. J Sep Sci. 34:3339–3343. 2011. View Article : Google Scholar : PubMed/NCBI
23	Lusis AJ: Atherosclerosis. Nature. 407:233–241. 2000. View Article : Google Scholar : PubMed/NCBI
24	Tangirala RK, Bischoff ED, Joseph SB, et al: Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA. 99:11896–11901. 2002. View Article : Google Scholar : PubMed/NCBI
25	Westerterp M, Bochem AE, Yvan-Charvet L, Murphy AJ, Wang N and Tall AR: ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ Res. 114:157–170. 2014. View Article : Google Scholar : PubMed/NCBI
26	Calpe-Berdiel L, Zhao Y, de Graauw M, et al: Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice. Atherosclerosis. 223:332–341. 2012. View Article : Google Scholar : PubMed/NCBI
27	Zhu X, Lee JY, Timmins JM, et al: Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem. 283:22930–22941. 2008. View Article : Google Scholar : PubMed/NCBI
28	Kumar H, Kim BW, Song SY, Kim JS, Kim IS, Kwon YS, Koppula S and Choi DK: Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms. Biosci Biotechnol Biochem. 76:1518–1522. 2012. View Article : Google Scholar : PubMed/NCBI
29	Geng Y, Li C, Liu J, Xing G, Zhou L, Dong M, Li X and Niu Y: Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats. Biol Pharm Bull. 33:836–843. 2010. View Article : Google Scholar : PubMed/NCBI
30	Rodríguez-Páez L, Juárez-Sanchez M, Antúnez-Solís J, Baeza I and Wong C: Alpha-asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats. Phytomedicine. 10:397–404. 2003. View Article : Google Scholar : PubMed/NCBI
31	De Filippis B, Giancristofaro A, Ammazzalorso A, D’Angelo A, Fantacuzzi M, Giampietro L, Maccallini C, Petruzzelli M and Amoroso R: Discovery of gemfibrozil analogues that activate PPARα and enhance the expression of gene CPT1A involved in fatty acids catabolism. Eur J Med Chem. 46:5218–5224. 2011. View Article : Google Scholar : PubMed/NCBI